Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOVIE INC. Director's Dealing 2019

Mar 14, 2019

35090_dirs_2019-03-14_8ddc3fd8-47ef-4c0b-b630-7c8860a94a58.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOVIE INC. (bivi)
CIK: 0001580149
Period of Report: 2018-11-01

Reporting Person: MARKHAM PENELOPE (Chief Science Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
options $0.25 2021-11-16 Common Stock (100000) Direct
options $0.1 2023-01-19 Common Stock (100000) Direct
options $0.025 2024-01-19 Common Stock (100000) Direct